Harrow Health Inc
NASDAQ:HROW

Watchlist Manager
Harrow Health Inc Logo
Harrow Health Inc
NASDAQ:HROW
Watchlist
Price: 42.9 USD -2.23% Market Closed
Market Cap: 1.5B USD
Have any thoughts about
Harrow Health Inc?
Write Note

Wall Street
Price Targets

HROW Price Targets Summary
Harrow Health Inc

Wall Street analysts forecast HROW stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HROW is 62.07 USD with a low forecast of 50.9 USD and a high forecast of 76.65 USD.

Lowest
Price Target
50.9 USD
19% Upside
Average
Price Target
62.07 USD
45% Upside
Highest
Price Target
76.65 USD
79% Upside

HROW Last Price Targets
Harrow Health Inc

The latest public price target was made on Oct 18, 2024 by Sahil Kazmi from B.Riley Financial , who expects HROW stock to rise by 70% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Sahil Kazmi
B.Riley Financial
73 USD
Upside 70%
1 month ago
Oct 18, 2024
Harrow Health (HROW) PT Raised to $73 at B.Riley
StreetInsider
Brooks O'Neil
Lake Street
55 USD
Upside 28%
1 month ago
Oct 4, 2024
Harrow price target raised to $55 from $45 at Lake Street
TheFly
Chase Knickerbocker
Craig-Hallum
45 USD
Upside 5%
3 months ago
Aug 9, 2024
Harrow price target raised to $45 from $30 at Craig-Hallum
TheFly
Chase Knickerbocker
Craig-Hallum
30 USD
Downside 30%
5 months ago
Jun 21, 2024
Harrow price target raised to $30 from $26 at Craig-Hallum
TheFly
Brooks O'Neil
Loop Capital Markets
25 USD
Downside 42%
5 months ago
Jun 3, 2024
Harrow Health (HROW) PT Raised to $25 at Lake Street Capital Markets
StreetInsider
Brooks O'Neil
Lake Street
25 USD
Downside 42%
5 months ago
Jun 3, 2024
Harrow price target raised to $25 from $20 at Lake Street
TheFly
Show More Price Targets
Show Less Price Targets
Sahil Kazmi
B.Riley Financial
Price Target 73 USD
Upside/Downside 70%
View Source
Brooks O'Neil
Lake Street
Price Target 55 USD
Upside/Downside 28%
View Source
Chase Knickerbocker
Craig-Hallum
Price Target 45 USD
Upside/Downside 5%
View Source
Chase Knickerbocker
Craig-Hallum
Price Target 30 USD
Upside/Downside 30%
View Source
Brooks O'Neil
Loop Capital Markets
Price Target 25 USD
Upside/Downside 42%
View Source
Brooks O'Neil
Lake Street
Price Target 25 USD
Upside/Downside 42%
View Source
Show More Price Targets
Show Less Price Targets
Harrow Health Inc Competitors:
Price Targets
688321
Shenzhen Chipscreen Biosciences Co Ltd
59% Upside
128940
Hanmi Pharm Co Ltd
52% Upside
CIPLA
Cipla Ltd
12% Upside
SUPN
Supernus Pharmaceuticals Inc
11% Upside
4503
Astellas Pharma Inc
27% Upside
300705
Hunan Jiudian Pharmaceutical Co Ltd
41% Upside
ANCR
Animalcare Group PLC
26% Upside
4530
Hisamitsu Pharmaceutical Co Inc
7% Upside

Revenue
Forecast

Revenue Estimate
Harrow Health Inc

For the last 8 years the compound annual growth rate for Harrow Health Inc's revenue is 38%. The projected CAGR for the next 3 years is 54%.

38%
Past Growth
54%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Harrow Health Inc

The compound annual growth rate of Harrow Health Inc's operating income for the next 3 years is 425%.

N/A
Past Growth
425%
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Net Income
Forecast

Net Income Estimate
Harrow Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HROW's stock price target?
Price Target
62.07 USD

According to Wall Street analysts, the average 1-year price target for HROW is 62.07 USD with a low forecast of 50.9 USD and a high forecast of 76.65 USD.

What is Harrow Health Inc's Revenue forecast?
Projected CAGR
54%

For the last 8 years the compound annual growth rate for Harrow Health Inc's revenue is 38%. The projected CAGR for the next 3 years is 54%.

What is Harrow Health Inc's Operating Income forecast?
Projected CAGR
425%

The compound annual growth rate of Harrow Health Inc's operating income for the next 3 years is 425%.

Back to Top